Filter Results:
(30,629)
Show Results For
- All HBS Web
(30,629)
- People (95)
- News (9,085)
- Research (16,302)
- Events (125)
- Multimedia (683)
- Faculty Publications (12,950)
Show Results For
- All HBS Web
(30,629)
- People (95)
- News (9,085)
- Research (16,302)
- Events (125)
- Multimedia (683)
- Faculty Publications (12,950)
- Oct 2012
- Book
Producing Prosperity: Why America Needs a Manufacturing Renaissance
In many cases, once manufacturing capabilities go away, so does much of the ability to innovate and compete. Manufacturing, it turns out, really matters in an innovation-driven economy. View Details
- 11 Jul 2016
- HBS Case
Neurodiversity: The Benefits of Recruiting Employees with Cognitive Disabilities
the thinking on this idea of neurodiversity; that we do better when we mix people who think differently or are wired a bit differently.” Social difficulties are one of the hallmarks of ASD, making it hard for those with ASD to make View Details
- 11 Jan 2016
- Research & Ideas
Is Group Loyalty a Force for Good or Evil?
Most ethical principles are pretty unambiguously good. Honesty, fairness, compassion—sure they have their downsides (being “honest to a fault”), but that’s more a by-product of something good than it is something evil in and of itself.... View Details
Keywords: by Michael Blanding
- Research Summary
Overview
My research broadly examines design choices of management control systems, with a special focus on organizational culture as an informal control mechanism and how it interacts with other formal control system View Details
- September 2005 (Revised June 2006)
- Case
WuXi PharmaTech
By: Richard G. Hamermesh and Simin Zhou
WuXi Pharmatech has gone from zero to $21 million in sales in three years. The company must decide its growth strategy and how best to finance and organize for rapid growth. View Details
Keywords: Growth Management; Capital Markets; Problems and Challenges; Pharmaceutical Industry; China
Hamermesh, Richard G., and Simin Zhou. "WuXi PharmaTech." Harvard Business School Case 806-003, September 2005. (Revised June 2006.)
- March 2002
- Case
Anthony Neoh
By: Guhan Subramanian, Michelle Kalka and Qian Sun
This case provides a brief history of the development of the Chinese securities market and details Anthony Neoh's involvement with it. It concentrates particularly on exploring issues specific to emerging markets. View Details
Subramanian, Guhan, Michelle Kalka, and Qian Sun. "Anthony Neoh." Harvard Business School Case 902-204, March 2002.
- October 2001 (Revised June 2002)
- Case
Centagenetix (A): Building a Business Model for Genetic Longevity
Describes a start-up company seeking to exploit population genetic data from long-lived, healthy people. The company must address legal, financial, ethical, and personal issues among its team to launch the company. View Details
Chesbrough, Henry W., and Frank Angella. "Centagenetix (A): Building a Business Model for Genetic Longevity." Harvard Business School Case 602-087, October 2001. (Revised June 2002.)
- January 1984
- Background Note
Just-in-Time Production Controlled by Kanban
Describes the method of control of repetitive manufacturing as used at Toyota by Just-in-Time and Kanban. The objective is to facilitate an understanding of how the method works and its rationale. View Details
Rhea, James T. "Just-in-Time Production Controlled by Kanban." Harvard Business School Background Note 684-047, January 1984.
- 05 Oct 2015
- News
What Companies Should Not Do in the Next Banking Crisis
- 10 Sep 2020
- News
Faculty Perspectives on the HBS Case Method
- 19 Sep 2018
- News
Uninformed Consent
- 28 Aug 2018
- News
Look Out Keurig, Here Comes The Smoodi Smoothie-Making Machine
- 10 Apr 2018
- News
'More than 600 apps had access to my iPhone data'
- 30 May 2017
- News
Latest College Graduates Enter A More Optimistic Economy
- 02 Aug 2022
- Research & Ideas
6 Strategies for Building Socially Responsible—and Profitable—Companies
A dozen years ago, Harvard Business School Professor George Serafeim wondered why some companies operated with an eye toward the greater good, while most did not. Back then, he always got the same response: Corporate leaders thought social and environmental practices... View Details
Keywords: by Lane Lambert
- 2024
- Article
Neyman Meets Causal Machine Learning: Experimental Evaluation of Individualized Treatment Rules
By: Michael Lingzhi Li and Kosuke Imai
A century ago, Neyman showed how to evaluate the efficacy of treatment using a randomized experiment under a minimal set of assumptions. This classical repeated sampling framework serves as a basis of routine experimental analyses conducted by today’s scientists across... View Details
Li, Michael Lingzhi, and Kosuke Imai. "Neyman Meets Causal Machine Learning: Experimental Evaluation of Individualized Treatment Rules." Journal of Causal Inference 12, no. 1 (2024).
- May 2022
- Supplement
Borusan CAT: Monetizing Prediction in the Age of AI (B)
By: Navid Mojir and Gamze Yucaoglu
Borusan Cat is an international distributor of Caterpillar heavy machines. In 2021, it had been three years since Ozgur Gunaydin (CEO) and Esra Durgun (Director of Strategy, Digitization, and Innovation) started working on Muneccim, the company’s predictive AI tool.... View Details
Keywords: AI and Machine Learning; Commercialization; Technology Adoption; Industrial Products Industry; Turkey; Middle East
Mojir, Navid, and Gamze Yucaoglu. "Borusan CAT: Monetizing Prediction in the Age of AI (B)." Harvard Business School Supplement 522-045, May 2022.
- 1980
- Working Paper
Components of Manufacturing Inventories: A Structural Model of the Production Process
By: Alan J. Auerbach and Jerry R. Green
This paper presents a structural model of production and inventory accumulation based on the hypothesis of cost minimization. It differs from previous attempts in several respects. First, it integrates the analysis of input inventories with output inventories, treating... View Details
Auerbach, Alan J., and Jerry R. Green. "Components of Manufacturing Inventories: A Structural Model of the Production Process." NBER Working Paper Series, No. 491, June 1980.
- January 2021 (Revised June 2021)
- Case
Eaton Corporation: Portfolio Transformation and the Cost of Capital (Abridged)
By: Benjamin C. Esty, E. Scott Mayfield and Daniel Fisher
In 2000, Eaton Corporation was a broadly diversified industrial conglomerate. But its strategy was evolving and its focus was narrowing around “power management” and more recently on “intelligent power,” the use of digitally enabled products and services designed to... View Details
Keywords: Mergers and Acquisitions; Business Conglomerates; Business Divisions; Cost of Capital; Corporate Finance; Value; Valuation; Industrial Products Industry; United States; Denmark; Republic of Ireland
Esty, Benjamin C., E. Scott Mayfield, and Daniel Fisher. "Eaton Corporation: Portfolio Transformation and the Cost of Capital (Abridged)." Harvard Business School Case 221-070, January 2021. (Revised June 2021.)